Bontia Bio is using its patented synthetic biology platform to produce a well-studied but previously inaccessible family of ...
Ltd. (New Filing) (CUPR) is planning to raise $16 million in an initial public offering on the week of March 24th, IPO Scoop reports. The company will issue 3,800,000 shares at a price of $4.00-$4.50 ...
Ltd. (New Filing) (CUPR) is planning to raise $16 million in an IPO on the week of March 24th, IPO Scoop reports. The company will issue 3,800,000 shares at $4.00-$4.50 per share. In the last year, ...
Co-Founders Professor Emily Parker and Dr Matthew Nicholson News from Bontia Bio Kiwi biotechnology company Bontia Bio has ...
It looks like you're using an old browser. To access all of the content on Yr, we recommend that you update your browser. It looks like JavaScript is disabled in your browser. To access all the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results